Evidence map›Paper›PMID 41834292›Full record

ArticleAdvanced materials (Deerfield Beach, Fla.)2026

Deployable 3D-Printed Vascular Stent with Surface-Catalysed Endogenous Nitric Oxide Generation.

Kun Zhou, Zifei Han, Kang Lin, Di Wu, Siti Nur Asyura Adzlan, Qingqing Fan, Christina Cortez-Jugo, Rona Chandrawati, Cyrille Boyer

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Advanced materials (Deerfield Beach, Fla.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Kun ZhouSchool of Chemical Engineering, UNSW, Sydney, New South Wales, Australia.ORCID https://orcid.org/0000-0003-4109-5926
Zifei HanSchool of Chemical Engineering, UNSW, Sydney, New South Wales, Australia.
Kang LinSchool of Chemical Engineering, UNSW, Sydney, New South Wales, Australia.
Di WuSchool of Chemical Engineering, UNSW, Sydney, New South Wales, Australia.
Siti Nur Asyura AdzlanSchool of Chemical Engineering, UNSW, Sydney, New South Wales, Australia.
Qingqing FanDepartment of Chemical Engineering, The University of Melbourne, Parkville, Victoria, Australia.
Christina Cortez-JugoDepartment of Chemical Engineering, The University of Melbourne, Parkville, Victoria, Australia.
Rona ChandrawatiSchool of Chemical Engineering, UNSW, Sydney, New South Wales, Australia.
Cyrille BoyerSchool of Chemical Engineering, UNSW, Sydney, New South Wales, Australia.ORCID https://orcid.org/0000-0002-4564-4702

Funding

Australian Research Council FL220100016National Health and Medical Research Council Emerging Leadership Investigator APP1173428
6 · The paper itself

Abstract

Atherosclerosis, a leading cause of heart attacks and strokes through the formation of vascular blockages, has become a major global healthcare challenge, with patient numbers expected to rise. Balloon-based angioplasty and stenting, the most common clinical treatments, have evolved over decades with advances in material biocompatibility, biodegradability, and device design. However, they still face critical issues such as tissue damage, inflammation, and restenosis, which can lead to implant failure and necessitate repeated surgeries, severely affecting patients' quality of life. To address the urgent need for a long-term stable stent system, we present a deployable 3D-printed vascular stent with surface-catalyzed endogenous nitric oxide (NO) generation (DSENO), offering a promising new direction for stent development. Unlike traditional stents, the DSENO can be deployed remotely using magnetic force and heat, eliminating the need for a catheter or balloon and thereby reducing the risk of tissue injury. Furthermore, its surface is modified to catalyze intracellular NO generation from endogenous S-nitrosothiols, which inhibits smooth muscle cell proliferation to prevent restenosis.

Indexed as

Nitric OxidePrinting, Three-DimensionalStentsAnimalsCatalysisCell ProliferationHumansMyocytes, Smooth MuscleS-NitrosothiolsSurface PropertiesNitric OxideS-Nitrosothiolsdeployable vascular stentendogenous nitric oxide catalysisshape‐memory materialspatiotemporal control

Identifiers

PMID41834292
PMCPMC13073119

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.